LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged patent system · clear

USPTO Policy

Innovation in China

In 2012, Chinese inventors filed more patent applications than those in any other country--including the United States. In a recent Booz & Company report (Ed: now Strategy&) , the authors surveyed many major Chinese and multinational companies to explore…

January 14, 2013·USPTO Policy·3 min read
Unsorted

Pros and cons of patents and prizes

"In a sense, the patent system is itself a prize system, albeit a peculiar one." In a 2007 paper Joseph Stiglitz, Columbia University professor and former World Bank chief economist, argues for more generalized use of prizes to stimulate and…

December 21, 2012·Unsorted·4 min read
USPTO Policy

Problems at the USPTO: Experts and Expertise (Part 4 of 4)

This articles is the last of a four-part series examining the USPTO’s role in administering the patent system. Other articles in this series: Part I: Introduction . Part II:Human Resources . Part III: Databases . In previous articles we introduced a…

November 8, 2012·USPTO Policy·4 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.